Gene-editing tool CRISPR/Cas9 shown to limit impact of certain parasitic diseases
Researchers have successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, which affects more than a quarter of a billion people in Southeast Asia, sub-Saharan Africa, and Latin America.
Original source: https://www.sciencedaily.com/releases/2019/01/190115132916.htm
